Gambol Pet Group Co., Ltd. (301498.SZ) Bundle
Investors eyeing Gambol Pet Group Co., Ltd. get a data-rich snapshot: Q3 2025 revenue jumped to CNY 1.52 billion (a 21.85% sequential rise) and TTM revenue hit CNY 6.31 billion (up 29.16% YoY), supporting a market capitalization of CNY 27.84 billion as of December 17, 2025; profitability appears solid with a TTM net profit margin of 10.57%, EPS of CNY 1.66 (P/E 41.71), ROE at 15.63% and EBITDA of CNY 851.93 million, while conservative leverage (debt-to-equity 5.60%, equity ratio 94.40%) pairs with healthy liquidity (current ratio 1.50, quick ratio 1.20, cash and equivalents CNY 635.48 million and operating cash flow CNY 719.6 million); valuation metrics (P/S 4.41, P/E 41.71) sit above industry averages with analyst targets of CNY 86.20-98.41, balanced against operational risks like raw material price swings, regulatory shifts, competition and supply-chain volatility and growth levers including international expansion, new product development, e-commerce investment and premium positioning.
Gambol Pet Group Co., Ltd. (301498.SZ) - Revenue Analysis
Gambol Pet Group's recent top-line performance shows accelerating sales growth driven by product mix, channel expansion and increased per-store and e-commerce throughput. Key figures to anchor the analysis are presented below.- Q3 2025 revenue: CNY 1.52 billion (quarter-over-quarter growth: +21.85%).
- Trailing twelve months (TTM) revenue: CNY 6.31 billion (year-over-year growth: +29.16%).
- Full-year 2024 revenue: CNY 5.24 billion (2024 vs 2023 growth: +21.22%).
- Revenue per employee: CNY 1.43 million across 4,425 employees.
- Price-to-Sales (P/S) ratio: 4.41x.
- Market capitalization (as of 2025-12-17): CNY 27.84 billion.
| Metric | Value | Change |
|---|---|---|
| Q3 2025 Revenue | CNY 1.52 billion | QoQ +21.85% |
| TTM Revenue | CNY 6.31 billion | YoY +29.16% |
| FY 2024 Revenue | CNY 5.24 billion | YoY +21.22% |
| Employees | 4,425 | - |
| Revenue per Employee | CNY 1.43 million | - |
| P/S Ratio | 4.41x | - |
| Market Capitalization | CNY 27.84 billion | As of 2025-12-17 |
- Implication: a TTM revenue of CNY 6.31 billion combined with a CNY 27.84 billion market cap yields the stated P/S of ~4.41x (27.84 / 6.31 ≈ 4.41).
- Operational efficiency: revenue per employee at CNY 1.43 million provides a productivity benchmark versus peers in pet products and consumer staples.
- Growth momentum: sequential and annual growth rates (QoQ +21.85% in Q3; TTM YoY +29.16%) indicate both recent acceleration and sustained expansion through 2024-2025.
Gambol Pet Group Co., Ltd. (301498.SZ) - Profitability Metrics
Gambol Pet Group's recent trailing twelve months (TTM) metrics show a company with solid profit generation and margin structure, supported by healthy operational cashflow and shareholder returns.- Net profit margin (TTM): 10.57% - indicates effective cost controls relative to revenue.
- Gross margin (TTM): 42.53% - a robust buffer between revenue and cost of goods sold, supporting pricing power and product mix resilience.
- EBITDA (TTM): CNY 851.93 million - strong operating performance before non-cash and financing items.
- Return on equity (ROE): 15.63% - efficient use of shareholders' equity to generate profits.
- Earnings per share (EPS, TTM): CNY 1.66; Price-to-earnings (P/E): 41.71 - reflects current market valuation relative to earnings.
- Dividend yield: 1.12%; Annualized payout: CNY 0.75 per share - demonstrates a moderate return of capital to shareholders.
| Metric | Value | Notes |
|---|---|---|
| Net Profit Margin (TTM) | 10.57% | Profit after tax as % of revenue |
| Gross Margin (TTM) | 42.53% | Revenue minus COGS as % of revenue |
| EBITDA (TTM) | CNY 851.93 million | Operational cash-generation proxy |
| ROE | 15.63% | Net income / average shareholders' equity |
| EPS (TTM) | CNY 1.66 | Earnings attributable to each outstanding share |
| P/E Ratio | 41.71 | Share price / EPS |
| Dividend Yield | 1.12% | Annual dividend / current share price |
| Annualized Dividend per Share | CNY 0.75 | Cash returned to shareholders per share over the year |
- High gross margin and solid EBITDA imply strong core product economics and operational leverage.
- ROE above mid-teens signals attractive returns on equity but should be viewed alongside leverage and capital structure.
- P/E of 41.71 suggests market expectations for continued growth; investors should compare this to peers and growth rates.
- Dividend yield of 1.12% provides modest income; payout of CNY 0.75 indicates a policy of returning some profits while retaining capital for growth.
Gambol Pet Group Co., Ltd. (301498.SZ) - Debt vs. Equity Structure
Gambol Pet Group Co., Ltd. (301498.SZ) exhibits a capital structure that is heavily weighted toward equity, signaling conservative financial management and low leverage. Key metrics point to a firm with minimal reliance on borrowed funds and sufficient earnings to service interest obligations.- Total debt-to-equity ratio: 5.60% - a conservative leverage position compared with industry averages.
- Equity ratio: 94.40% - indicates that nearly all assets are financed through shareholders' equity.
- Debt ratio: 5.60% - low proportion of total assets funded by liabilities, implying lower financial risk.
- Interest coverage ratio: 15.63 - ample ability to cover interest expenses from operating earnings.
- Capital structure predominantly equity-based, minimizing reliance on debt financing and interest burden.
- Low debt levels provide flexibility to pursue future investments or strategic initiatives without immediate refinancing pressure.
| Metric | Value | Implication |
|---|---|---|
| Total debt-to-equity ratio | 5.60% | Conservative leverage; limited creditor claims relative to equity |
| Equity ratio | 94.40% | Strong equity base; high solvency |
| Debt ratio | 5.60% | Low portion of assets financed by debt |
| Interest coverage ratio | 15.63 | Comfortable coverage of interest payments; low default risk |
| Primary financing source | Equity | Reduced exposure to interest rate fluctuations |
| Financial flexibility | High | Capacity to fund capex or M&A with limited new debt |
Gambol Pet Group Co., Ltd. (301498.SZ) - Liquidity and Solvency
Gambol Pet Group shows a solid short-term and long-term financial posture driven by healthy liquidity metrics, meaningful cash reserves and strong operating cash generation. Key metrics and implications are summarized below.- Current ratio: 1.50 - adequate short-term coverage of liabilities.
- Quick ratio: 1.20 - sufficient immediate liquidity excluding inventories.
- Cash & cash equivalents: CNY 635.48 million - a meaningful cash buffer for working capital and opportunistic needs.
- Cash flow from operations: CNY 719.6 million - exceeds reported net income, indicating high-quality earnings and strong cash conversion.
- Solvency metrics: within industry norms, supported by low leverage and comfortable interest coverage.
- Low debt levels - enhance resilience in economic downturns and provide flexibility for investment or M&A.
| Metric | Value | Implication |
|---|---|---|
| Current Ratio | 1.50 | Meets short-term obligations with buffer |
| Quick Ratio | 1.20 | Immediate liquidity excluding inventory |
| Cash & Cash Equivalents | CNY 635.48 million | Liquid buffer for operations and opportunities |
| Operating Cash Flow | CNY 719.6 million | Cash generation exceeds net income - high-quality earnings |
| Estimated Debt-to-Equity | ~0.25 | Low leverage relative to peers |
| Interest Coverage (Estimated) | ~12x | Comfortable ability to service interest |
- Investor takeaways: strong cash position and operating cash flow reduce refinancing risk and support strategic flexibility.
- Risks to monitor: working capital swings, inventory trends, and any shift in leverage if management pursues larger acquisitions.
- For corporate direction and long-term priorities, see: Mission Statement, Vision, & Core Values (2026) of Gambol Pet Group Co., Ltd.
Gambol Pet Group Co., Ltd. (301498.SZ) - Valuation Analysis
Gambol Pet Group's current valuation profile points to a premium-growth pricing environment. Key headline metrics show elevated multiples relative to peers and broader sector averages, indicating investor optimism about future earnings and revenue expansion.- P/E ratio: 41.71 - priced at a significant premium to earnings.
- P/S ratio: 4.41 - implies the market values the company at ~4.41× annual revenue.
- Market capitalization: CNY 27.84 billion (as of 2025-12-17).
- Analyst price targets range: CNY 86.20 to CNY 98.41, suggesting upside potential from current market pricing.
- Valuation metrics exceed industry averages, reflecting expectations of above-market growth.
| Metric | Value | Context / Implication |
|---|---|---|
| P/E (TTM) | 41.71 | High multiple vs. typical pet industry P/E (often mid-teens to low-20s), signaling growth premium. |
| P/S (TTM) | 4.41 | ~4.41× revenue; elevated vs. many consumer-packaged-goods peers. |
| Market Cap | CNY 27.84 billion | Snapshot as of 17-Dec-2025. |
| Analyst Price Target Range | CNY 86.20 - CNY 98.41 | Range implies analyst confidence and potential upside; consider dispersion for risk assessment. |
| Relative to Industry | Higher | Valuation metrics above industry averages, consistent with premium growth positioning. |
- Implications for investors:
- Premium multiples mean expectations for continued revenue and margin expansion; execution risk carries greater price sensitivity.
- High P/E magnifies the impact of earnings misses; monitor quarterly guidance and margin trends closely.
- P/S of 4.41 highlights revenue growth as a key valuation driver-track organic sales, channel expansion, and pricing power.
- Data & further company background: Gambol Pet Group Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money
Gambol Pet Group Co., Ltd. (301498.SZ) - Risk Factors
Investors should weigh several tangible risk vectors that materially affect Gambol Pet Group Co., Ltd. (301498.SZ). Below are the principal risks with quantifiable context and scenario-based sensitivity to help gauge potential impact on margins, cash flow and earnings.
- Fluctuations in raw material prices
- Regulatory changes in the pet food industry
- Economic downturns reducing pet-product spending
- Intense competition from domestic and international brands
- Supply chain disruptions affecting availability and costs
- Currency exchange rate fluctuations impacting international revenue
Key numeric exposures and stress scenarios
| Exposure / Metric | Assumption / Base | Stress Scenario | Estimated Impact |
|---|---|---|---|
| Raw materials as % of revenue (mixed ingredients & packaging) | ~44% of revenue (assumed industry-aligned base) | Raw material +10% | Cost of goods up ~4.4% of revenue → gross margin down 4.4 p.p. |
| Gross margin (illustrative) | ~28-34% range (industry comparable) | After +10% raw material shock | New gross margin ~23.6-29.6% |
| Exports / international revenue | ~10-20% of total revenue (typical mid-size pet groups) | FX depreciation of home currency 8% | Revenue translation swing ±8% for export portion → overall rev ±0.8-1.6% |
| Supply chain disruption probability | Baseline: 10-15% annual chance (logistics & supplier interruptions) | Major port/logistics halt (30-60 days) | Working capital tied up; incremental logistics +2-5% of cost for affected period |
| Demand sensitivity in downturn | Pet discretionary spend elasticity: -0.6 to -1.0 | GDP contraction -3% | Estimated revenue decline 1.8-3.0% |
| Competitive pricing pressure | Market share shifts ±1-3% annually in contested segments | Aggressive pricing by a national competitor | Margin compression 1-3 p.p.; potential market-share loss up to 3% |
How these risks typically manifest operationally
- Raw material volatility: spike in meat, grain, or oil-derived packaging costs directly raises COGS and forces pricing or margin concessions.
- Regulatory changes: new ingredient, labeling or safety standards can require capex for reformulation, testing or line changes - one-off compliance costs often in the low-to-mid millions RMB for mid-sized producers.
- Economic downturns: discretionary premium product lines see first demand pullback; private-label or value tiers may gain share, pressuring ASP and blended margins.
- Competition: intensified promotions and longer trade credit cycles increase working capital needs and reduce realized pricing.
- Supply chain risks: single-source suppliers or concentrated logistics routes raise supplier concentration risk and amplify cost spikes if disrupted.
- Currency swings: even modest FX moves create earnings volatility when exports account for a meaningful share of revenue or when imported inputs are priced in foreign currency.
Quantitative monitoring checklist for investors
- Raw-material cost per tonne and % of revenue trend (quarterly)
- Gross margin and gross margin sensitivity to input prices (quarterly)
- Export share of revenue and hedging policy (quarterly disclosure)
- Inventory days and receivable days (working capital stress indicator)
- Capex and one-off regulatory compliance spend (annually)
- Market-share movement in core SKUs and price/mix trends (quarterly)
For background on the company's structure and revenue model, see: Gambol Pet Group Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money
Gambol Pet Group Co., Ltd. (301498.SZ) - Growth Opportunities
Gambol Pet Group Co., Ltd. (301498.SZ) sits at an inflection point where domestic leadership in China can be parlayed into scalable international growth, premiumization, omnichannel expansion, and sustainability-driven product differentiation. The following analysis highlights concrete opportunity vectors, market sizing context, and strategic initiatives that investors should monitor.- Addressable market scale: the global pet care market is measured in the hundreds of billions USD, with pet food and consumables representing the majority of spend - providing a large TAM for Gambol to target with focused expansion.
- Domestic strength as leverage: strong brand recognition and distribution in China can accelerate international entry costs being lower than for greenfield competitors.
| Market / Region | Estimated Market Size (Annual) | Typical CAGR (Recent) | Key Demand Drivers |
|---|---|---|---|
| United States | ~$120-140 billion (pet care total, 2023 est.) | 3-5% (mature) | Premiumization, wellness-focused diets, strong e‑commerce |
| Europe | ~$35-45 billion (pet care total, 2023 est.) | 2-4% | Regulation-driven quality focus, private-label competition, premium brands |
| Japan | ~$10-12 billion (pet care total, 2023 est.) | 1-2% (aging population; smaller households) | High willingness to pay for premium, health-oriented products |
| South Korea | ~$3-6 billion (pet care total, 2023 est.) | 7-10% (rapid growth) | Urban pet ownership, premium and novel formats (fresh/frozen) |
| China (context) | ~RMB 300-450 billion (pet-related market, recent years est.) | 8-12% (historical, premiumization ongoing) | Rising pet ownership, premium and health-conscious demand |
- Expansion into international markets (U.S., Europe, Japan, South Korea)
- Market-entry pathways: cross-border e-commerce pilots, regional distribution partnerships, and targeted product introductions in premium segments.
- KPIs to watch: international revenue share, gross margin differential by region, unit economics of cross-border logistics.
- Development of new product lines to cater to diverse pet needs
- Priorities: breed/age-specific formulations, veterinary/therapeutic lines, fresh/frozen or refrigerated options, and functional snacks (digestive, joint, skin).
- R&D metrics: product development cycle time, SKU margin, repeat-purchase rate, and contribution to basket size.
- Strategic partnerships and acquisitions to enhance market presence
- Targets: regional distributors, niche premium brands, pet-health tech startups, or manufacturing assets to improve margins and local compliance.
- Financial focus: acquisition payback period, EBITDA multiple paid, and post-deal integration synergies.
- Investment in e-commerce platforms to reach a broader customer base
- Actions: optimize direct-to-consumer (DTC) channels, marketplace presence (Tmall, JD, Amazon, local platforms), subscription models for recurring revenue.
- Metrics: CAC, LTV, repeat purchase rate, subscription churn, and share of online sales.
- Leveraging brand recognition to introduce premium product offerings
- Approach: tiered branding (value, core, premium), celebrity or vet endorsements, limited-edition/region-specific premium launches.
- Financial impact: premiumization typically expands ASP (average selling price) and gross margin; watch margin expansion and brand elasticity.
- Adoption of sustainable and health-focused ingredients to appeal to conscious consumers
- Trends: clean-label, novel protein sources, transparent sourcing, recyclable packaging, and low-carbon claims.
- Investor signals: R&D spend on sustainable sourcing, cost delta for premium ingredients, and premium price realization.
- Key execution considerations for investors
- Supply chain resilience: ability to scale production while maintaining ingredient traceability and margin targets.
- Regulatory compliance: pet food/import approvals and labeling requirements differ substantially across U.S., EU, Japan, and Korea.
- Capital allocation: balancing CAPEX for manufacturing/export, M&A deployment, and marketing behind new market launches.
Gambol Pet Group Co., Ltd. (301498.SZ) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.